Perrigo Company Profile (NYSE:PRGO)

About Perrigo

Perrigo logoPerrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Related Products
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: PRGO
  • CUSIP: 71429010
Key Metrics:
  • Previous Close: $81.95
  • 50 Day Moving Average: $86.66
  • 200 Day Moving Average: $91.47
  • 52-Week Range: $79.72 - $152.36
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 10.83
  • P/E Growth: 0.00
  • Market Cap: $11.75B
  • Outstanding Shares: 143,374,000
  • Beta: 0.72
  • Net Margins: -26.62%
  • Return on Equity: 10.78%
  • Return on Assets: 5.44%
  • Debt-to-Equity Ratio: 0.65%
  • Current Ratio: 1.71%
  • Quick Ratio: 1.13%
Additional Links:
Companies Related to Perrigo:

Analyst Ratings

Consensus Ratings for Perrigo (NYSE:PRGO) (?)
Ratings Breakdown: 1 Sell Rating, 15 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.11)
Consensus Price Target: $110.53 (34.88% upside)

Analysts' Ratings History for Perrigo (NYSE:PRGO)
DateFirmActionRatingPrice TargetDetails
11/16/2016B. RileyReiterated RatingNeutral$97.00View Rating Details
11/10/2016JPMorgan Chase & Co.Set Price TargetHold$95.00View Rating Details
11/11/2016Bank of America Corp.UpgradeUnderperform -> NeutralView Rating Details
10/24/2016RBC Capital MarketsSet Price TargetHold$92.00View Rating Details
9/27/2016ArgusReiterated RatingHoldView Rating Details
9/15/2016GuggenheimSet Price TargetBuy$125.00View Rating Details
9/13/2016Deutsche Bank AGReiterated RatingBuy$105.00View Rating Details
8/11/2016Jefferies GroupLower Price TargetHold$97.00 -> $84.00View Rating Details
8/10/2016Leerink SwannSet Price TargetHold$96.00 -> $81.00View Rating Details
8/11/2016Barclays PLCLower Price TargetOverweight$120.00 -> $110.00View Rating Details
8/11/2016Northland SecuritiesDowngradeOutperform -> Market Perform$123.00 -> $94.00View Rating Details
6/17/2016BTIG ResearchReiterated RatingNeutralView Rating Details
6/15/2016Raymond James Financial Inc.Reiterated RatingHoldView Rating Details
6/3/2016Royal Bank Of CanadaReiterated RatingSector Perform$109.00View Rating Details
5/14/2016Morgan StanleyReiterated RatingHoldView Rating Details
4/26/2016Goldman Sachs Group Inc.Reiterated RatingSell$124.00 -> $95.00View Rating Details
4/25/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
4/25/2016Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
2/22/2016William BlairReiterated RatingMarket PerformView Rating Details
6/23/2015BMO Capital MarketsInitiated CoverageOutperform$246.00View Rating Details
(Data available from 12/9/2014 forward)


Earnings History for Perrigo (NYSE:PRGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016Q316$1.58$1.65$1.28 billion$1.40 billionViewN/AView Earnings Details
8/10/2016Q216$1.98$1.93$1.43 billion$1.48 billionViewListenView Earnings Details
5/12/2016Q116$1.75$1.75$1.35 billion$1.34 billionViewListenView Earnings Details
2/18/2016Q415$1.93$1.80$1.46 billion$1.42 billionViewListenView Earnings Details
10/22/2015Q3$1.73$1.76$1.42 billion$1.34 billionViewListenView Earnings Details
8/5/2015Q2$1.96$2.18$1.52 million$1.53 millionViewN/AView Earnings Details
4/21/2015Q315$1.78$1.85$1.10 billion$1.05 billionViewN/AView Earnings Details
2/5/2015Q215$1.79$1.82$1.09 billion$1.07 billionViewN/AView Earnings Details
11/6/2014Q115$1.44$1.40$997.90 million$951.50 millionViewN/AView Earnings Details
8/14/2014Q414$1.55$1.74$1.09 billion$1.14 billionViewN/AView Earnings Details
5/7/2014Q314$1.51$1.31$1.07 billion$1,000.00 millionViewN/AView Earnings Details
2/6/2014Q214$1.59$1.87$996.68 million$979.00 millionViewN/AView Earnings Details
10/31/2013Q114$1.40$1.52$900.10 million$933.00 millionViewN/AView Earnings Details
8/15/2013Q4 2013$1.56$1.57$999.08 million$967.20 millionViewN/AView Earnings Details
5/7/2013Q3 2013$1.44$1.42$935.44 million$919.83 millionViewN/AView Earnings Details
2/1/2013Q2 2013$1.31$1.36$881.84 million$882.96 millionViewN/AView Earnings Details
11/7/2012Q113$1.24$1.27$825.83 million$769.80 millionViewN/AView Earnings Details
8/16/2012$1.27$1.28ViewN/AView Earnings Details
5/8/2012$1.22$1.41ViewN/AView Earnings Details
2/7/2012$1.15$1.20ViewN/AView Earnings Details
10/27/2011$1.06$1.10ViewN/AView Earnings Details
8/16/2011$0.97$1.02ViewN/AView Earnings Details
5/3/2011$0.97$1.07ViewN/AView Earnings Details
2/1/2011$0.95$1.05ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Perrigo (NYSE:PRGO)
Current Year EPS Consensus Estimate: $6.98 EPS
Next Year EPS Consensus Estimate: $7.57 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$2.27$2.27$2.27
Q2 20161$2.47$2.47$2.47
Q3 20161$2.25$2.25$2.25
Q4 20161$2.42$2.42$2.42
(Data provided by Zacks Investment Research)


Current Dividend Information for Perrigo (NYSE:PRGO)
Annual Dividend:$0.58
Dividend Yield:0.71%
Dividend Growth:14.90% (3 Year Average)
Payout Ratio:-5.53% (Based on Trailing 12 Months of Earnings)
8.31% (Based on Current Year Consensus EPS Estimate)
7.66% (Based on Next Year Consensus EPS Estimate)
Track Record:13 Years of Consecutive Dividend Growth

Dividend History for Perrigo (NYSE:PRGO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Perrigo (NYSE:PRGO)
Insider Ownership Percentage: 4.47%
Institutional Ownership Percentage: 69.37%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/25/2016Judy L BrownEVPSell2,097$89.44$187,555.68View SEC Filing  
11/21/2016Geoffrey M ParkerDirectorBuy2,500$88.75$221,875.00View SEC Filing  
10/24/2016Judy L BrownEVPSell2,092$90.42$189,158.64View SEC Filing  
9/26/2016Judy L BrownCFOSell2,096$96.76$202,808.96View SEC Filing  
9/26/2016Thomas FarringtonEVPSell1,110$96.76$107,403.60View SEC Filing  
9/9/2016Gary K Kunkle JrDirectorSell5,814$89.95$522,969.30View SEC Filing  
9/8/2016Herman Morris JrDirectorSell1,073$90.96$97,600.08View SEC Filing  
8/26/2016Judy L BrownEVPSell2,095$88.28$184,946.60View SEC Filing  
4/13/2016Judy L BrownCFOSell2,776$126.22$350,386.72View SEC Filing  
3/18/2016Michael J JandernoaDirectorSell761$128.29$97,628.69View SEC Filing  
3/2/2016Sharon KochanEVPSell1,490$125.28$186,667.20View SEC Filing  
2/24/2016Judy L BrownCFOSell2,776$123.73$343,474.48View SEC Filing  
1/6/2016Judy L. BrownCFOSell27,737$142.41$3,950,026.17View SEC Filing  
12/28/2015Joseph C. PapaChairmanSell10,183$147.07$1,497,613.81View SEC Filing  
8/25/2015John T. HendricksonEVPSell1,737$181.37$315,039.69View SEC Filing  
8/25/2015Todd W. KingmaVPSell1,715$181.37$311,049.55View SEC Filing  
8/24/2015John T. HendricksonEVPSell4,468$177.68$793,874.24View SEC Filing  
4/29/2015Todd W KingmaVPSell1,700$190.27$323,459.00View SEC Filing  
4/14/2015John T HendricksonEVPSell8,800$200.27$1,762,376.00View SEC Filing  
4/13/2015Todd W KingmaVPSell1,300$198.44$257,972.00View SEC Filing  
3/13/2015Jatin ShahSVPSell2,000$165.50$331,000.00View SEC Filing  
10/1/2014Judy L BrownCFOSell3,515$150.72$529,780.80View SEC Filing  
9/3/2014Sharon KochanEVPSell1,116$150.00$167,400.00View SEC Filing  
9/3/2014Todd W KingmaVPSell2,250$149.65$336,712.50View SEC Filing  
9/2/2014Judy L BrownCFOSell3,515$149.32$524,859.80View SEC Filing  
9/2/2014Thomas FarringtonVPSell1,741$150.36$261,776.76View SEC Filing  
8/27/2014Michael Robert StewartVPSell4,519$148.78$672,336.82View SEC Filing  
8/26/2014Jeffrey NeedhamVPSell10,205$148.54$1,515,850.70View SEC Filing  
8/26/2014Judy L BrownCFOSell4,827$148.87$718,595.49View SEC Filing  
8/25/2014John T HendricksonEVPSell2,533$148.44$375,998.52View SEC Filing  
5/15/2014Ran GottfriedDirectorSell1,000$131.25$131,250.00View SEC Filing  
3/24/2014Joseph PapaChairmanSell10,000$157.72$1,577,200.00View SEC Filing  
1/16/2014Joseph PapaChairmanSell5,000$157.59$787,950.00View SEC Filing  
12/12/2013Gary CohenDirectorSell4,632$152.52$706,472.64View SEC Filing  
12/12/2013Joseph PapaChairmanSell15,000$150.12$2,251,800.00View SEC Filing  
12/9/2013Michael JandernoaDirectorSell128,620$155.30$19,974,686.00View SEC Filing  
11/25/2013Louis YuVPSell2,292$155.51$356,428.92View SEC Filing  
11/21/2013Judy BrownCFOSell9,988$154.74$1,545,543.12View SEC Filing  
11/20/2013John HendricksonEVPSell8,400$152.80$1,283,520.00View SEC Filing  
11/4/2013Ran GottfriedDirectorSell2,275$143.36$326,144.00View SEC Filing  
9/24/2013Joseph PapaChairmanSell15,000$124.60$1,869,000.00View SEC Filing  
9/18/2013John HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
9/11/2013Michael Robert StewartVPSell5,063$123.37$624,622.31View SEC Filing  
9/9/2013Louis YuVPSell1,852$124.11$229,851.72View SEC Filing  
9/6/2013John T HendricksonEVPSell1,000$123.46$123,460.00View SEC Filing  
9/4/2013John T HendricksonEVPSell2,000$123.92$247,840.00View SEC Filing  
9/3/2013Judy BrownCFOSell2,500$122.07$305,175.00View SEC Filing  
8/30/2013Jeffrey NeedhamVPSell6,585$120.47$793,294.95View SEC Filing  
8/29/2013Sharon KochanVPSell3,467$120.98$419,437.66View SEC Filing  
8/27/2013Joseph PapaChairmanSell15,000$117.64$1,764,600.00View SEC Filing  
8/26/2013John HendricksonEVPSell2,099$119.15$250,095.85View SEC Filing  
8/26/2013Judy BrownCFOSell3,424$119.28$408,414.72View SEC Filing  
8/20/2013John HendricksonEVPSell1,676$118.56$198,706.56View SEC Filing  
8/20/2013Judy BrownCFOSell2,804$118.58$332,498.32View SEC Filing  
8/20/2013Thomas FarringtonVPSell1,658$119.86$198,727.88View SEC Filing  
8/16/2013Todd KingmaVPSell1,250$120.00$150,000.00View SEC Filing  
7/19/2013Todd W KingmaVPSell1,250$129.37$161,712.50View SEC Filing  
7/11/2013Joseph C PapaChairmanSell10,000$128.54$1,285,400.00View SEC Filing  
7/9/2013John T HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
6/14/2013Joseph C PapaChairmanSell10,000$118.39$1,183,900.00View SEC Filing  
6/14/2013Todd W KingmaVPSell1,250$118.00$147,500.00View SEC Filing  
6/4/2013Judy L BrownCFOSell2,500$116.38$290,950.00View SEC Filing  
5/14/2013Sharon KochanVPSell2,647$119.64$316,687.08View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Perrigo (NYSE:PRGO)
DateHeadline logoBRIEF-Strides Shasun to acquire Perrigo's API facility in India (NYSE:PRGO) - December 9 at 3:49 AM logoETFs with exposure to Perrigo Co. Plc : December 8, 2016 (NYSE:PRGO) - December 8 at 7:46 PM logoPerrigo To Revamp Branded Consumer Healthcare's Belgium Business - Quick Facts (NYSE:PRGO) - December 8 at 9:11 AM logoPerrigo (PRGO) to Restructure BCH Omega Pharma Belgium Business; Will Terminate EuroGenerics Agreement (NYSE:PRGO) - December 8 at 9:11 AM logoPerrigo Announces Portfolio Review Developments And Intention To Restructure Branded Consumer Healthcare's Belgium Business (NYSE:PRGO) - December 8 at 9:11 AM logo6:37 am Perrigo to restructure the Branded Consumer Healthcare's Omega Pharma Belgium business; to sell the Etixx brand and its business effective January 1, 2017 (NYSE:PRGO) - December 8 at 9:11 AM logoBRIEF-Perrigo says will restructure its Belgium business (NYSE:PRGO) - December 8 at 8:27 AM logoWorst Performing Industries For December 6, 2016 (NYSE:PRGO) - December 6 at 12:15 PM
News IconLarge Cap Drug Related Products: Perrigo Company plc (NYSE:PRGO) (NYSE:PRGO) - December 5 at 7:13 PM
News IconTop Gainers of the Day: Perrigo Company plc (NYSE:PRGO) from Drug Related Products (NYSE:PRGO) - December 3 at 6:27 PM
News IconHedge Funds Are Buying Perrigo Company plc Ordinary Shares (PRGO) (NYSE:PRGO) - December 1 at 10:36 AM
News IconStock Tracker: Trend Analysis on Perrigo Co. (PRGO) - Yankee Analysts (NYSE:PRGO) - November 30 at 7:30 PM logoPerrigo Company Plc (PRGO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Market Study Published (NYSE:PRGO) - November 29 at 2:02 PM
News IconPerrigo Company plc Ordinary Shares (NYSE:PRGO) Ratings Coverage (NYSE:PRGO) - November 24 at 10:18 AM logoPerrigo Director buys 2,500 shares (NYSE:PRGO) - November 23 at 7:12 PM logoPerrigo Company PLC : Post Earnings Coverage as Perrigo Q3 Results Beat Expectations (NYSE:PRGO) - November 22 at 11:21 AM
News IconPerrigo Company Plc PRGO Financial and Strategic SWOT Analysis Review Prices from USD $300 (NYSE:PRGO) - November 22 at 11:21 AM
News IconDrug Related Products: Perrigo Company plc (NYSE:PRGO) Position of the day (NYSE:PRGO) - November 21 at 7:29 PM
News IconPerrigo Company Plc PRGO Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NYSE:PRGO) - November 19 at 6:59 PM logoEx-Dividend Reminder: Perrigo Company, Evercore Partners and Applied Materials (NYSE:PRGO) - November 18 at 12:01 PM
News IconPerrigo Company plc (NYSE:PRGO) from Drug Related Products – Todays Top Gains (NYSE:PRGO) - November 18 at 10:13 AM logoNYPD Union Goes After Drug Prices Amid DOJ Pharma Probe (NYSE:PRGO) - November 18 at 10:12 AM
News IconUpdate on Perrigo Company plc (NYSE:PRGO) for the day (NYSE:PRGO) - November 16 at 10:38 AM logoJeffrey Smith's Starboard Value Discloses Major Stake in Perrigo (PRGO) (NYSE:PRGO) - November 16 at 10:38 AM logoPerrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : November 15, 2016 (NYSE:PRGO) - November 15 at 10:40 AM logoWhy Did Valeant Revise Its 2016 EPS Guidance? (NYSE:PRGO) - November 15 at 10:40 AM logoETFs with exposure to Perrigo Co. Plc : November 14, 2016 (NYSE:PRGO) - November 14 at 7:16 PM
News IconToday’s Rating: Is Bank of America Very Positive For Perrigo Company (NYSE:PRGO) After Its Upgrade? (NYSE:PRGO) - November 11 at 6:43 PM logoPerrigo upgraded by BofA/Merrill (NYSE:PRGO) - November 11 at 6:43 PM logoPerrigo Co. Plc :PRGO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016 (NYSE:PRGO) - November 11 at 6:43 PM
News IconIs Perrigo Company plc (NYSE:PRGO), a large market cap stock a smart buy? (NYSE:PRGO) - November 11 at 9:47 AM logoEdited Transcript of PRGO earnings conference call or presentation 10-Nov-16 1:30pm GMT (NYSE:PRGO) - November 11 at 9:47 AM logoPerrigo to review options for multiple sclerosis drug royalties (NYSE:PRGO) - November 10 at 6:48 PM logoPerrigo Co. Q3 Earnings Drop 9% (NYSE:PRGO) - November 10 at 6:48 PM
News IconPerrigo Considering Strategic Alternatives for MS Drug (NYSE:PRGO) - November 10 at 6:48 PM logoEarnings Whisper: Perrigo Company plc (PRGO) and Ralph Lauren Corp (RL) (NYSE:PRGO) - November 10 at 6:48 PM logoPerrigo Company Plc to Review Strategic Alternatives for Tysabri® Royalty Stream (NYSE:PRGO) - November 10 at 6:48 PM logoPerrigo Plc (PRGO) Q3 2016 Results - Earnings Call Transcript (NYSE:PRGO) - November 10 at 6:48 PM logoPerrigo reports 3Q loss (NYSE:PRGO) - November 10 at 10:05 AM logoPerrigo Takes Waterland to Arbitration Over Omega Pharma Acquisition (NYSE:PRGO) - November 10 at 10:05 AM logoQ3 2016 Perrigo Company PLC Earnings Release - Before Market Open (NYSE:PRGO) - November 10 at 10:05 AM logoPERRIGO CO PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NYSE:PRGO) - November 10 at 10:05 AM logoPerrigo to review options for Multiple Sclerosis drug Tysabri (NYSE:PRGO) - November 10 at 10:05 AM logo[$$] Perrigo Considering Strategic Alternatives for MS Drug (NYSE:PRGO) - November 10 at 10:05 AM logoPerrigo (PRGO) Beats on Q3 Earnings, Revenues; View Intact (NYSE:PRGO) - November 10 at 10:05 AM logoStocks to Watch: Macy's, Hilton and Kohl's (NYSE:PRGO) - November 10 at 10:05 AM logoBRIEF-Perrigo Company PLc to review strategic alternatives for Tysabri royalty stream (NYSE:PRGO) - November 10 at 3:44 AM logoEarnings Whisper: Perrigo Company plc (PRGO) and Ralph Lauren Corp (RL) - TCC (NYSE:PRGO) - November 9 at 6:54 PM logoMedical Product Nov 10 Earnings Lineup: PRGO, GKOS, VIVO (NYSE:PRGO) - November 9 at 9:33 AM logoValeant Crashes On Q3 Sales, EPS Miss; Slashes 2016 Guidance (NYSE:PRGO) - November 8 at 6:42 PM


Perrigo (NYSE:PRGO) Chart for Friday, December, 9, 2016

Last Updated on 12/9/2016 by Staff